Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07036458
PHASE1
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Sponsor: JW Pharmaceutical
View on ClinicalTrials.gov
Summary
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Official title: An Open-label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C Epaminurad in Healthy Male Subjects
Key Details
Gender
MALE
Age Range
30 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2025-08-22
Completion Date
2026-01-09
Last Updated
2025-09-09
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
14C Epaminurad Oral Solution
Subjects will receive a single administration of 14C Epaminurad Oral Solution
Locations (1)
Quotient Science
Nottingham, United Kingdom